Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „adverse“
Suchtreffer
Begriffe & Kennungen
Abasaglar (previously Abasria) · 4.8 · Description of selected adverse reactions
Eintrag öffnenAbasaglar (previously Abasria) · 4.8 · Description of selected adverse reactions
Eintrag öffnenAbasaglar (previously Abasria) · 4.8 · Hypoglycaemia (very common), in general the most frequent adverse reaction of insulin therapy, may occur if th
Eintrag öffnenAbasaglar (previously Abasria) · 4.8 · Hypoglycaemia (very common), in general the most frequent adverse reaction of insulin therapy, may occur if th
Eintrag öffnenAbasaglar (previously Abasria) · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenAbasaglar (previously Abasria) · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenAbasaglar (previously Abasria) · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenAbasaglar (previously Abasria) · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenAbasaglar (previously Abasria) · 4.8 · Tabulated list of adverse reactions
Eintrag öffnenAbasaglar (previously Abasria) · 4.8 · Tabulated list of adverse reactions
Eintrag öffnenAbasaglar (previously Abasria) · 4.8 · The following related adverse reactions from clinical trials are listed below as MedDRA preferred term by syst
Eintrag öffnenAbasaglar (previously Abasria) · 4.8 · The following related adverse reactions from clinical trials are listed below as MedDRA preferred term by syst
Eintrag öffnenAbasaglar (previously Abasria) · 4.8 · Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.
Eintrag öffnenAbasaglar (previously Abasria) · 4.8 · Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.
Eintrag öffnenAbilify Maintena · 4.8 · Description of selected adverse reactions
Eintrag öffnenAbilify Maintena · 4.8 · Description of selected adverse reactions
Eintrag öffnenAbilify Maintena · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenAbilify Maintena · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenAbilify Maintena · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenAbilify Maintena · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnen